In vitro activity of recombinant lysostaphin in combination with linezolid, vancomycin and oxacillin against methicillin-resistant Staphylococcus aureus.
Year: 2017
Type: article
Abstract: BACKGROUND AND OBJECTIVES: (MRSA) clinical isolates was determined. MATERIALS AND METHODS: synergistic activity of lysostaphin with linezolid, vancomycin and oxacillin, by checkerboard assay. RESULTS: Lysostaphin showed synergistic activity with linezolid and oxacillin, against all MRSA isolates, tested in the present study. Whereas, only 19.1% of the isolates showed synergistic activity with vancomycin and remaining 80.9% of the MRSA isolates showed additive activity. CONCLUSION: studies are warranted to confirm our results.
Source: Europe PMC (PubMed Central)
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2768401666
